Dr. Yusuf Menda, MD
Claim this profileThe University of Iowa Theranostics Center
Area of expertise
Neuroendocrine Tumors
Yusuf Menda, MD has run 5 trials for Neuroendocrine Tumors. Some of their research focus areas include:
Carcinoid Tumor
Yusuf Menda, MD has run 4 trials for Carcinoid Tumor. Some of their research focus areas include:
Affiliated Hospitals
The University Of Iowa Theranostics Center
University Of Iowa
Clinical Trials Yusuf Menda, MD is currently running
Targeted Alpha-Particle Therapy
for Neuroendocrine Tumors
This study is Phase I/IIa First-in-Human Study of \[212Pb\]VMT-α-NET Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Tumors
Recruiting
1 award
Phase 1 & 2
13 criteria
Lutetium-177 Therapy
for Neuroendocrine Tumors
The goal of this study is to learn if individualized dosimetry-based prescribing of Lutetium-177 DOTATATE (Lutathera, Novartis Pharmaceuticals) improves treatment outcomes for adults with unresectable neuroendocrine tumors. To investigate this, study participants will: * Undergo Somatostatin Receptor (SSTR) positron emission tomography (PET) imaging, such as a DOTATOC PET/CT scan * Be randomized to receive standard treatment (as per FDA guidelines) or investigational treatment (customized dosing of Lutathera based upon dosimetry) * Undergo blood tests for 4 to 8 weeks after each Lutathera treatment * Complete patient reported outcome questionnaires * Visit the clinic for follow-up about every 8 weeks.
Recruiting
1 award
Phase 2
4 criteria
More about Yusuf Menda, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Yusuf Menda, MD has experience with
- 203-Lead Pentixather SPECT/CT
- 212-Lead Pentixather
- Gallium-68 Pentixafor
- [212Pb]VMT01
- [212Pb]VMT-α-NET
- FPI-2265 (225Ac-PSMA-I&T)
Breakdown of trials Yusuf Menda, MD has run
Neuroendocrine Tumors
Carcinoid Tumor
Lung carcinoid
Paraganglioma
Adrenal Gland Pheochromocytoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Yusuf Menda, MD specialize in?
Yusuf Menda, MD focuses on Neuroendocrine Tumors and Carcinoid Tumor. In particular, much of their work with Neuroendocrine Tumors has involved Stage IV patients, or patients who are Stage III.
Is Yusuf Menda, MD currently recruiting for clinical trials?
Yes, Yusuf Menda, MD is currently recruiting for 3 clinical trials in Iowa City Iowa. If you're interested in participating, you should apply.
Are there any treatments that Yusuf Menda, MD has studied deeply?
Yes, Yusuf Menda, MD has studied treatments such as 203-Lead Pentixather SPECT/CT, 212-Lead Pentixather, Gallium-68 Pentixafor.
What is the best way to schedule an appointment with Yusuf Menda, MD?
Apply for one of the trials that Yusuf Menda, MD is conducting.
What is the office address of Yusuf Menda, MD?
The office of Yusuf Menda, MD is located at: The University of Iowa Theranostics Center, Iowa City, Iowa 52242 United States. This is the address for their practice at the The University of Iowa Theranostics Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.